Hyperuricosuric calcium urolithiasis
- PMID: 29368300
- DOI: 10.1007/s40620-018-0469-3
Hyperuricosuric calcium urolithiasis
Abstract
Hyperuricosuric calcium urolithiasis is a condition of mixed calcium oxalate stones characterized by hyperuricosuria either in isolation or in conjunction with other risk factors for calcium oxalate stones such as hypercalciuria, hyperoxaluria, and hypocitraturia. There are three proposed physicochemical models of pathogenesis where urate in its crystalline phase via heterogeneous nucleation, in its colloidal phase via removal of crystallization inhibitors, and in solution via precipitation crystallization, can all increase propensity to calcium oxalate precipitation. Regardless of the model, the phenomenologic observation of urate increasing calcium oxalate precipitation appears solid. Another supporting factor are retrospective data analysis and prospective trials showing uric acid lowering reduces stones events in hyperuricosuric calcium stone formers. Due to the heterogeneity of pathogenesis of calcium oxalate stones in the unselected stone-formers, association cannot be demonstrated between uric acid excretion rate and risk of kidney stone the general population. In calcium oxalate stoners with isolated hyperuricosuria or hyperuricosuria in combination with other calcium stone risks where treatment of these traditional risks fails to reduce stone formation, urate acid lowering should be cautiously attempted. More refinement of pathogenic models and prospective controlled trials in phenotypically defined subgroups of subjects with calcium oxalate urolithiasis will be informative.
Keywords: Calcium oxalate; Hyperuricosuria; Urolithiasis.
Similar articles
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study.Am J Kidney Dis. 2024 Jul;84(1):83-93.e1. doi: 10.1053/j.ajkd.2023.12.015. Epub 2024 Mar 1. Am J Kidney Dis. 2024. PMID: 38432593 Free PMC article.
-
Dietary interventions for preventing complications in idiopathic hypercalciuria.Cochrane Database Syst Rev. 2014 Feb 11;2014(2):CD006022. doi: 10.1002/14651858.CD006022.pub4. Cochrane Database Syst Rev. 2014. PMID: 24519664 Free PMC article.
-
The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.Scand J Urol Nephrol Suppl. 1980;53:265-71. Scand J Urol Nephrol Suppl. 1980. PMID: 6938003
-
Therapeutic potential of oxalate decarboxylase (OxDC) in the treatment of urolithiasis (kidney stone diseases).Int J Biol Macromol. 2025 Jul;318(Pt 3):145168. doi: 10.1016/j.ijbiomac.2025.145168. Epub 2025 Jun 10. Int J Biol Macromol. 2025. PMID: 40505910 Review.
Cited by
-
Relationship Between the ApaI (rs7975232), BsmI (rs1544410), FokI (rs2228570), and TaqI (rs731236) Variants in the Vitamin D Receptor Gene and Urolithiasis Susceptibility: An Updated Meta-Analysis and Trial Sequential Analysis.Front Genet. 2020 Apr 15;11:234. doi: 10.3389/fgene.2020.00234. eCollection 2020. Front Genet. 2020. PMID: 32346382 Free PMC article.
-
Decreased Associated Risk of Gout in Diabetes Patients with Uric Acid Urolithiasis.J Clin Med. 2019 Sep 25;8(10):1536. doi: 10.3390/jcm8101536. J Clin Med. 2019. PMID: 31557790 Free PMC article.
-
Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017".J Nephrol. 2019 Oct;32(5):681-698. doi: 10.1007/s40620-019-00587-1. Epub 2019 Jan 24. J Nephrol. 2019. PMID: 30680550
-
Kidney stone disease: risk factors, pathophysiology and management.Nat Rev Nephrol. 2025 Aug 11. doi: 10.1038/s41581-025-00990-x. Online ahead of print. Nat Rev Nephrol. 2025. PMID: 40790363 Review.
-
Uric Acid and Urate in Urolithiasis: The Innocent Bystander, Instigator, and Perpetrator.Semin Nephrol. 2020 Nov;40(6):564-573. doi: 10.1016/j.semnephrol.2020.12.003. Semin Nephrol. 2020. PMID: 33678311 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources